Maki Sakuma

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Recent advances in the development of small chemical compounds that can modulate RNA splicing brought excitement to the field of splicing-targeting therapy. Splicing-targeting therapy tries to ameliorate the disease by altering the exon combination of transcripts to reduce the undesired effect of genetic mutations. However, the knowledge and tools to(More)
  • 1